New Design Esophageal Stents for the Palliation of Dysphagia From Esophageal or Gastric Cardia Cancer: A Randomized Trial
- 1 February 2008
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 103 (2) , 304-312
Abstract
Stents are often used for the palliation of inoperable esophageal or gastric cardia cancer. One of the drawbacks of the currently used stents is the high percentage of recurrent dysphagia due to stent migration and tissue growth. New stents have been designed to overcome this unwanted sequela of stent placement. In the present study, we investigated whether results of stent placement could be improved with newer stent designs. Between June 2004 and May 2006, 125 patients with dysphagia from inoperable carcinoma of the esophagus or gastric cardia were randomized to placement of an Ultraflex stent (N = 42), Polyflex stent (N = 41), or Niti-S stent (N = 42). Patients were followed by scheduled telephone calls at 14 days after treatment, and then monthly for 6 months or until death. Technical and functional outcome, complications, recurrent dysphagia, and survival were analyzed with, χ2 tests, Kaplan-Meier curves, and log-rank tests. Stent placement was technically successful in all patients with an Ultraflex stent, in 34/41 (83%) patients with a Polyflex stent, and in 40/42 (95%) patients treated with a Niti-S stent (P = 0.008). Dysphagia score improved from a median of 3 (liquids only) to 1 (ability to eat some solid food) in all patients. There were no differences in complications among the three stent types. Recurrent dysphagia, caused by tissue in- or overgrowth, migration, or food obstruction, was significantly different between patients with an Ultraflex stent and patients with a Polyflex stent or Niti-S stent (22 [52%] vs 15 [37%] vs 13 [31%], P = 0.03). Stent migration occurred more frequently with Polyflex stents, whereas tissue in- or overgrowth was more frequently seen with Ultraflex stents, and to a lesser degree, Niti-S stents. No differences were found in survival (median survival: Ultraflex stent 132 days vs Polyflex stent 102 days vs Niti-S stent 159 days) among the three stent types. All three stents are safe and offer adequate palliation of dysphagia from esophageal or gastric cardia cancer. Nonetheless, Polyflex stents seem the least preferable in this patient group, as placement of this device is technically demanding and associated with a high rate of stent migrations.Keywords
This publication has 17 references indexed in Scilit:
- A new esophageal stent design (Niti-S stent) for the prevention of migration: a prospective study in 42 patientsGastrointestinal Endoscopy, 2006
- Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trialThe Lancet, 2004
- Improved Prognosis of Resected Esophageal CancerWorld Journal of Surgery, 2004
- Palliation of Esophageal Carcinoma with a New Self-Expanding Plastic StentEndoscopy, 2003
- Leakage of Jejunal End of Roux Limb after Total Gastrectomy: Management with a Placement of a Covered Metallic Stent: Case ReportJournal of Korean Medical Science, 2003
- Guidelines for the management of oesophageal and gastric cancerGut, 2002
- Use of the Polyflex stent in the palliative therapy ofesophageal carcinomaSurgical Endoscopy, 2001
- A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junctionAmerican Journal of Gastroenterology, 2001
- Nonmalignant obstruction is a common problem with metal stents in the treatment of esophageal cancerGastrointestinal Endoscopy, 2000
- Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy.Gut, 1982